Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs
- PMID: 3884413
- DOI: 10.1016/0303-7207(85)90131-5
Keoxifene shows pure antiestrogenic activity in pituitary gonadotrophs
Abstract
Estrogens increase both basal and LHRH-induced LH release in rat anterior pituitary cells in culture. Following 48 h of preincubation with 1 nM 17 beta-estradiol, the maximal LH response to LHRH is increased 1.5-fold while the ED50 value of LHRH action is decreased 2.5-fold from 500 to 200 pM. The maximal 3-fold stimulation of 0.3 nM LHRH-induced LH release by 17 beta-estradiol is exerted at a KD value of 14.4 pM. Keoxifene (300 nM) completely blocks the potent stimulatory effect of 17 beta-estradiol up to 1 nM, the highest concentration of the estrogen used. As shown by the complete reversal of the stimulatory effect of 0.1 and 1.0 nM 17 beta-estradiol by keoxifene at IC50 values of 7.7 and 34 nM respectively, the antiestrogen interacts competitively with 17 beta-estradiol at the estrogen binding site. When present alone, keoxifene shows no estrogenic activity. The present data show that keoxifene acts as a pure antiestrogen on the control of LHRH-induced LH release in rat pituitary gonadotrophs.
Similar articles
-
Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs.J Steroid Biochem. 1987 May;26(5):539-46. doi: 10.1016/0022-4731(87)90005-7. J Steroid Biochem. 1987. PMID: 2953941
-
Inhibitory actions of keoxifene on luteinizing hormone secretion in pituitary gonadotrophs.Endocrinology. 1988 Aug;123(2):962-8. doi: 10.1210/endo-123-2-962. Endocrinology. 1988. PMID: 3293992
-
Weak estrogenic activity of phenol red in the pituitary gonadotroph: re-evaluation of estrogen and antiestrogen effects.J Steroid Biochem. 1990 Jan;35(1):17-22. doi: 10.1016/0022-4731(90)90139-j. J Steroid Biochem. 1990. PMID: 2407899
-
Interactions between 17 beta-estradiol and progesterone in the control of luteinizing hormone and follicle-stimulating hormone release in rat anterior pituitary cells in culture.Endocrinology. 1981 Jan;108(1):52-7. doi: 10.1210/endo-108-1-52. Endocrinology. 1981. PMID: 6780315
-
Site of action for the estradiol-induced luteinizing hormone surge in farm animals and primates.Domest Anim Endocrinol. 1988 Oct;5(4):265-81. doi: 10.1016/0739-7240(88)90001-x. Domest Anim Endocrinol. 1988. PMID: 3073037 Review. No abstract available.
Cited by
-
Raloxifene.Drugs Aging. 1998 Apr;12(4):335-41; discussion 342. doi: 10.2165/00002512-199812040-00006. Drugs Aging. 1998. PMID: 9571395 Review.
-
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.Breast Cancer Res Treat. 1988 Oct;12(2):213-25. doi: 10.1007/BF01805942. Breast Cancer Res Treat. 1988. PMID: 3242650
-
Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk.World J Urol. 2003 May;21(1):31-6. doi: 10.1007/s00345-002-0316-x. Epub 2003 Feb 14. World J Urol. 2003. PMID: 12756492 Review.
-
Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen, and ICI 164384, a new steroidal antiestrogen, in ZR-75-1 human breast cancer cells.Breast Cancer Res Treat. 1989 Oct;14(1):65-76. doi: 10.1007/BF01805977. Breast Cancer Res Treat. 1989. PMID: 2605344
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials